Search results
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 5 days agoCompared to the Large Cap Pharmaceuticals industry's P/E of 14.2X, shares of Novartis are trading at...
Amplify Debuts New Weight Loss Drug ETF | ETF Trends
ETF Trends· 5 days agoAdditionally, the fund aims to provide investors with results similar to the performance of the VettaFi Weight Loss Drug & Treatment Index (THINR). THINR...
Leverkusen the soccer team is famous. The city not so much
KSL Salt Lake City· 5 days agoAn often-overlooked, small German city dominated by the pharmaceuticals industry is making an...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk,...
Zacks via Yahoo Finance· 3 days agoYou can see all of today’s research reports here >>> Shares of Novo Nordisk have outperformed the...
Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance· 2 days agoAs the market closed yesterday, the Large Cap Pharmaceuticals industry was having an average PEG...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoSystImmune, Inc. Announces Transition of Chief Medical Officer PR Newswire REDMOND, Wash., May 23, 2024 REDMOND, Wash., May 23, 2024 /PRNewswire/ -- SystImmune, Inc., a pioneering clinical-stage biopharmaceutical company focused on developing novel
Column: Big Pharma giveaway will increase working families' health costs
The Salem News· 3 days agoSmall business owners are the drivers of the U.S. economy. Our innovation, creativity, and willingness to take risks ensure a steady supply of job creation and economic activity. Unlike the ...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 6 days agoActavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. Forest...
Axios Vitals
Axios· 4 days agoAfter pitched battles over Medicare drug price negotiations, Congress may be pivoting to more bipartisan ground: overhaul of the patent system that allows brand-name drugs to delay competition ...
Wegovy should be treating more than obesity
The Eagle-Tribune· 2 days agoA new analysis found that the profound benefits of Novo Nordisk’s obesity drug Wegovy for people at risk of heart attacks or strokes don’t depend on the...
